301096 百诚医药
交易中 11-05 09:50:21
资讯
新帖
简况
百诚医药（301096）10月30日主力资金净买入556.78万元
证券之星 · 11-02
百诚医药（301096）10月30日主力资金净买入556.78万元
百诚医药（301096）2026年三季报简析：净利润同比下降1433.26%，三费占比上升明显
证券之星 · 10-31
百诚医药（301096）2026年三季报简析：净利润同比下降1433.26%，三费占比上升明显
股市必读：百诚医药三季报 - 第三季度单季净利润同比下降2851.09%
证券之星 · 10-30
股市必读：百诚医药三季报 - 第三季度单季净利润同比下降2851.09%
图解百诚医药三季报：第三季度单季净利润同比下降2851.09%
证券之星 · 10-29
图解百诚医药三季报：第三季度单季净利润同比下降2851.09%
百诚医药（301096）10月27日主力资金净买入954.21万元
证券之星 · 10-28
百诚医药（301096）10月27日主力资金净买入954.21万元
10月27日百诚医药跌7.03%，融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 10-27
10月27日百诚医药跌7.03%，融通健康产业灵活配置混合A/B基金重仓该股
百诚医药（301096）披露与关联方共同投资设立合资公司暨关联交易公告，10月26日股价上涨6.03%
证券之星 · 10-26
百诚医药（301096）披露与关联方共同投资设立合资公司暨关联交易公告，10月26日股价上涨6.03%
股市必读：百诚医药新发布《第四届董事会第十五次会议决议公告》
证券之星 · 10-26
股市必读：百诚医药新发布《第四届董事会第十五次会议决议公告》
百诚医药（301096）10月20日主力资金净买入208.91万元
证券之星 · 10-21
百诚医药（301096）10月20日主力资金净买入208.91万元
百诚医药（301096）10月13日主力资金净买入521.75万元
证券之星 · 10-14
百诚医药（301096）10月13日主力资金净买入521.75万元
百诚医药（301096）9月24日主力资金净卖出755.95万元
证券之星 · 09-28
百诚医药（301096）9月24日主力资金净卖出755.95万元
百诚医药（301096）披露注销募集资金现金管理专用结算账户公告，9月23日股价上涨1.27%
证券之星 · 09-23
百诚医药（301096）披露注销募集资金现金管理专用结算账户公告，9月23日股价上涨1.27%
股市必读：百诚医药中报 - 第二季度单季净利润同比下降138.28%
证券之星 · 08-28
股市必读：百诚医药中报 - 第二季度单季净利润同比下降138.28%
百诚医药（301096）2026年中报简析：净利润同比下降48.43%，公司应收账款体量较大
证券之星 · 08-28
百诚医药（301096）2026年中报简析：净利润同比下降48.43%，公司应收账款体量较大
百诚医药(301096)6月30日股东户数1.17万户，较上期增加4.48%
证券之星 · 08-27
百诚医药(301096)6月30日股东户数1.17万户，较上期增加4.48%
图解百诚医药中报：第二季度单季净利润同比下降138.28%
证券之星 · 08-27
图解百诚医药中报：第二季度单季净利润同比下降138.28%
百诚医药（301096）披露2026年半年度报告，8月26日股价下跌2.68%
证券之星 · 08-26
百诚医药（301096）披露2026年半年度报告，8月26日股价下跌2.68%
百诚医药（301096）披露全资子公司部分药品中选国家药品集中采购公告，8月11日股价上涨2.36%
证券之星 · 08-11
百诚医药（301096）披露全资子公司部分药品中选国家药品集中采购公告，8月11日股价上涨2.36%
百诚医药最新公告：全资子公司西格列汀二甲双胍缓释片中选第十二批国家药品集采
证券之星 · 08-11
百诚医药最新公告：全资子公司西格列汀二甲双胍缓释片中选第十二批国家药品集采
股市必读：百诚医药（301096）7月31日董秘有最新回复
证券之星 · 08-03
股市必读：百诚医药（301096）7月31日董秘有最新回复
加载更多
公司概况
公司名称：
杭州百诚医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-12-20
主营业务：
杭州百诚医药科技股份有限公司的主营业务是为各类制药企业、医药研发投资企业提供医药技术受托研发服务（CRO业务）、研发技术成果转化服务、定制研发生产服务（CDMO）。公司的主要产品是药学研究、临床试验、注册申报、研发技术成果转化、定制研发生产服务（CDMO）、自主创新药物研发、受托创新药物研发。
发行价格：
79.60
{"stockData":{"symbol":"301096","market":"SZ","secType":"STK","nameCN":"百诚医药","latestPrice":44.08,"timestamp":1793843421000,"preClose":43.72,"halted":0,"volume":455200,"delay":0,"changeRate":0.0082,"floatShares":83114599,"shares":109000000,"eps":-1.6312,"marketStatus":"交易中","change":0.36,"latestTime":"11-05 09:50:21","open":43.72,"high":44.34,"low":43.58,"amount":20000000,"amplitude":0.0174,"askPrice":44.11,"askSize":535,"bidPrice":44.08,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-1.6312,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1793849400000},"marketStatusCode":2,"adr":0,"adjPreClose":43.72,"symbolType":"stock","openAndCloseTimeList":[[1793842200000,1793849400000],[1793854800000,1793862000000]],"highLimit":48.09,"lowLimit":39.35,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":109228284,"isCdr":false,"pbRate":1.97,"roa":"--","roe":"--","epsLYR":-0.83,"committee":-0.905759,"marketValue":4815000000,"turnoverRate":0.0055,"status":0,"floatMarketCap":3664000000},"requestUrl":"/m/hq/s/301096","defaultTab":"news","newsList":[{"id":"2680786917","title":"百诚医药（301096）10月30日主力资金净买入556.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680786917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680786917?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:08","pubTimestamp":1793581701,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，百诚医药报收于43.06元，上涨1.75%，换手率4.43%，成交量3.68万手，成交额1.58亿元。10月30日的资金流向数据方面，主力资金净流入556.78万元，占总成交额3.52%，游资资金净流出692.27万元，占总成交额4.38%，散户资金净流入135.49万元，占总成交额0.86%。融券方面，融券卖出800.0股，融券偿还1500.0股，融券余量6100.0股，融券余额26.27万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200003320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679226689","title":"百诚医药（301096）2026年三季报简析：净利润同比下降1433.26%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2679226689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679226689?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:56","pubTimestamp":1793404590,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期百诚医药发布2026年三季报。截至本报告期末，公司营业总收入4.5亿元，同比下降11.78%，归母净利润-8165.17万元，同比下降1433.26%。本报告期百诚医药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达43.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100017598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679232229","title":"股市必读：百诚医药三季报 - 第三季度单季净利润同比下降2851.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679232229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679232229?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:32","pubTimestamp":1793309551,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第三季度单季度归母净利润为-8324.94万元，同比下降2851.09%。公司公告汇总：公司拟注销已回购股份777,300股，总股本将由109,228,284股减至108,450,984股。业绩披露要点财务报告2026年前三季度主营收入4.5亿元，同比下降11.78%；归母净利润-8165.17万元，同比下降1433.26%；扣非净利润-1.09亿元，同比下降684.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000007372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679410418","title":"图解百诚医药三季报：第三季度单季净利润同比下降2851.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679410418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679410418?lang=zh_cn&edition=full","pubTime":"2026-10-29 02:12","pubTimestamp":1793211134,"startTime":"0","endTime":"0","summary":"证券之星消息，百诚医药2026年三季报显示，前三季度公司主营收入4.5亿元，同比下降11.78%；归母净利润-8165.17万元，同比下降1433.26%；扣非净利润-1.09亿元，同比下降684.81%；其中2026年第三季度，公司单季度主营收入1.45亿元，同比下降18.1%；单季度归母净利润-8324.94万元，同比下降2851.09%；单季度扣非净利润-8772.25万元，同比下降3910.79%；负债率34.14%，投资收益990.17万元，财务费用1424.61万元，毛利率41.15%。财报数据概要请见下图:本文数据来源于百诚医药2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678438492","title":"百诚医药（301096）10月27日主力资金净买入954.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678438492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678438492?lang=zh_cn&edition=full","pubTime":"2026-10-28 09:16","pubTimestamp":1793150201,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，百诚医药报收于43.0元，下跌7.03%，换手率4.79%，成交量3.98万手，成交额1.79亿元。10月27日的资金流向数据方面，主力资金净流入954.21万元，占总成交额5.33%，游资资金净流入233.79万元，占总成交额1.3%，散户资金净流出1188.0万元，占总成交额6.63%。近5日资金流向一览见下表：百诚医药融资融券信息显示，融资方面，当日融资买入1327.28万元，融资偿还943.53万元，融资净买入383.75万元，连续3日净买入累计2131.88万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800015305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678122540","title":"10月27日百诚医药跌7.03%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678122540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678122540?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:09","pubTimestamp":1793092148,"startTime":"0","endTime":"0","summary":"证券之星消息，10月27日百诚医药跌7.03%，收盘报43.0元，换手率4.79%，成交量3.98万手，成交额1.79亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700031946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678161623","title":"百诚医药（301096）披露与关联方共同投资设立合资公司暨关联交易公告，10月26日股价上涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678161623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678161623?lang=zh_cn&edition=full","pubTime":"2026-10-26 18:07","pubTimestamp":1793009245,"startTime":"0","endTime":"0","summary":"近日，杭州百诚医药科技股份有限公司发布《关于与关联方共同投资设立合资公司暨关联交易的公告》。公告显示，公司拟与关联方深圳智药科技有限公司共同投资设立合资公司杭州百晶生物科技有限公司，注册资本2000万元，百诚医药以自有资金出资1400万元，持股70%，智药科技出资600万元，持股30%。本次关联交易已经公司董事会及独立董事专门会议审议通过，无需提交股东大会审议，不构成重大资产重组。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600024951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678136322","title":"股市必读：百诚医药新发布《第四届董事会第十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678136322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678136322?lang=zh_cn&edition=full","pubTime":"2026-10-26 02:00","pubTimestamp":1792951240,"startTime":"0","endTime":"0","summary":"公司公告汇总第四届董事会第十五次会议决议公告杭州百诚医药科技股份有限公司于2026年10月23日召开第四届董事会第十五次会议，审议通过《关于与关联方共同投资设立合资公司暨关联交易的议案》。由于公司非独立董事蒋一得同时担任智药科技非独立董事，本次交易构成关联交易。本次关联交易已经公司董事会及独立董事专门会议审议通过，无需提交股东大会审议，不构成重大资产重组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677764385","title":"百诚医药（301096）10月20日主力资金净买入208.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677764385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677764385?lang=zh_cn&edition=full","pubTime":"2026-10-21 09:06","pubTimestamp":1792544772,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月20日收盘，百诚医药报收于43.2元，上涨5.6%，换手率3.79%，成交量3.15万手，成交额1.34亿元。10月20日的资金流向数据方面，主力资金净流入208.91万元，占总成交额1.56%，游资资金净流出745.89万元，占总成交额5.57%，散户资金净流入536.98万元，占总成交额4.01%。融券方面，融券卖出2800.0股，融券偿还900.0股，融券余量6000.0股，融券余额25.92万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100008125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675346399","title":"百诚医药（301096）10月13日主力资金净买入521.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675346399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675346399?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:09","pubTimestamp":1791940197,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，百诚医药报收于42.18元，下跌4.38%，换手率4.76%，成交量3.96万手，成交额1.64亿元。近5日资金流向一览见下表：百诚医药融资融券信息显示，融资方面，当日融资买入1380.97万元，融资偿还854.38万元，融资净买入526.59万元。融券方面，融券卖出0.0股，融券偿还600.0股，融券余量5900.0股，融券余额24.89万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670407940","title":"百诚医药（301096）9月24日主力资金净卖出755.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670407940","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670407940?lang=zh_cn&edition=full","pubTime":"2026-09-28 09:21","pubTimestamp":1790558511,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，百诚医药报收于48.23元，下跌5.13%，换手率4.16%，成交量3.46万手，成交额1.71亿元。9月24日的资金流向数据方面，主力资金净流出755.95万元，占总成交额4.42%，游资资金净流入139.25万元，占总成交额0.81%，散户资金净流入616.69万元，占总成交额3.61%。融券方面，融券卖出300.0股，融券偿还2300.0股，融券余量2000.0股，融券余额9.65万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800002875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669810534","title":"百诚医药（301096）披露注销募集资金现金管理专用结算账户公告，9月23日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669810534","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669810534?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:18","pubTimestamp":1790173104,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，百诚医药报收于50.84元，较前一交易日上涨1.27%，最新总市值为55.53亿元。公司于2026年9月23日发布《关于注销募集资金现金管理专用结算账户的公告》。公告显示，杭州百诚医药科技股份有限公司因募集资金现金管理专用结算账户相关产品已全部到期赎回，且后续无使用计划，依据相关规定，已注销在申万宏源证券有限公司温州车站大道证券营业部开立的账号为1812177887的募集资金现金管理专用结算账户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300040957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603187","title":"股市必读：百诚医药中报 - 第二季度单季净利润同比下降138.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662603187?lang=zh_cn&edition=full","pubTime":"2026-08-28 07:00","pubTimestamp":1787871639,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度单季度归母净利润为-1121.47万元，同比下降138.28%；扣非净利润为-2920.02万元，同比下降219.42%。公司公告汇总：董事会审议通过使用剩余超募资金13,991.99万元永久补充流动资金，并定于2026年9月15日召开临时股东大会审议该议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662298039","title":"百诚医药（301096）2026年中报简析：净利润同比下降48.43%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662298039","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662298039?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:47","pubTimestamp":1787870838,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期百诚医药发布2026年中报。截至本报告期末，公司营业总收入3.04亿元，同比下降8.4%，归母净利润159.77万元，同比下降48.43%。按单季度数据看，第二季度营业总收入1.44亿元，同比下降29.29%，第二季度归母净利润-1121.47万元，同比下降138.28%。本报告期百诚医药公司应收账款体量较大，当期应收账款占最新年报营业总收入比达77.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703778","title":"百诚医药(301096)6月30日股东户数1.17万户，较上期增加4.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703778","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703778?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:18","pubTimestamp":1787825882,"startTime":"0","endTime":"0","summary":"证券之星消息，近日百诚医药披露，截至2026年6月30日公司股东户数为1.17万户，较3月31日增加502.0户，增幅为4.48%。在医疗服务行业个股中，百诚医药股东户数低于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.75万户。从股价来看，2026年3月31日至2026年6月30日，百诚医药区间涨幅为12.49%，在此期间股东户数增加502.0户，增幅为4.48%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749703","title":"图解百诚医药中报：第二季度单季净利润同比下降138.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749703","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662749703?lang=zh_cn&edition=full","pubTime":"2026-08-27 03:11","pubTimestamp":1787771475,"startTime":"0","endTime":"0","summary":"证券之星消息，百诚医药2026年中报显示，上半年度公司主营收入3.04亿元，同比下降8.4%；归母净利润159.77万元，同比下降48.43%；扣非净利润-2150.14万元，同比下降83.3%；其中2026年第二季度，公司单季度主营收入1.44亿元，同比下降29.29%；单季度归母净利润-1121.47万元，同比下降138.28%；单季度扣非净利润-2920.02万元，同比下降219.42%；负债率33.51%，投资收益485.78万元，财务费用943.21万元，毛利率47.13%。财报数据概要请见下图:本文数据来源于百诚医药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700007256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662474831","title":"百诚医药（301096）披露2026年半年度报告，8月26日股价下跌2.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662474831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662474831?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:46","pubTimestamp":1787755575,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，百诚医药报收于46.78元，较前一交易日下跌2.68%，最新总市值为51.1亿元。该股当日开盘47.64元，最高48.27元，最低46.35元，成交额达1亿元，换手率为2.57%。近日，百诚医药披露《2026年半年度报告》。报告显示，本报告期营业收入为304,442,101.61元，较上年同期下降8.40%；归属于上市公司股东的净利润为1,597,715.67元，同比下降48.43%；扣除非经常性损益后的净利润为-21,501,418.06元，同比下降83.30%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600053887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916103","title":"百诚医药（301096）披露全资子公司部分药品中选国家药品集中采购公告，8月11日股价上涨2.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658916103?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:10","pubTimestamp":1786457412,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，百诚医药报收于46.84元，较前一交易日上涨2.36%，最新总市值为51.16亿元。公司于近日披露《关于全资子公司部分药品中选国家药品集中采购的公告》。公告显示，杭州百诚医药科技股份有限公司全资子公司浙江赛默制药有限公司参与国家组织的第十二批药品集中采购，西格列汀二甲双胍缓释片两个规格产品中选。目前采购协议签订等后续事项仍存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999534","title":"百诚医药最新公告：全资子公司西格列汀二甲双胍缓释片中选第十二批国家药品集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999534","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658999534?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:41","pubTimestamp":1786441266,"startTime":"0","endTime":"0","summary":"百诚医药(301096.SZ)公告称，公司全资子公司浙江赛默制药有限公司参与第十二批全国药品集中采购，西格列汀二甲双胍缓释片中选。该药品适用于成人2型糖尿病患者，规格为磷酸西格列汀50mg/100mg联合盐酸二甲双胍500mg/1000mg。2025年度该产品暂未实现销售收入，若后续签订采购合同并实施，将有利于产品放量销售及市场开拓，对公司未来经营业绩产生积极影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100028662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656634373","title":"股市必读：百诚医药（301096）7月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2656634373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656634373?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:38","pubTimestamp":1785699494,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，百诚医药报收于37.82元，上涨5.17%，换手率4.32%，成交量3.59万手，成交额1.36亿元。董秘最新回复投资者： 公司与耀速科技的合作主要涉及哪些方面董秘： 尊敬的投资者您好，在前沿技术、产业资源与研发能力上，公司与包括耀速科技在内的行业伙伴一直保持着开放性的交流与探索。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301096","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793843425519,"stockEarnings":[{"period":"1week","weight":0.0248},{"period":"1month","weight":-0.1132},{"period":"3month","weight":0.0449},{"period":"6month","weight":-0.2771},{"period":"1year","weight":-0.2897},{"period":"ytd","weight":-0.2349}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.1181},{"period":"1year","weight":-0.0692},{"period":"ytd","weight":-0.0712}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州百诚医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"12586人(较上一季度增加7.41%)","perCapita":"6603股","listingDate":"2021-12-20","address":"浙江省杭州市临平区临平街道绿洲路159号","registeredCapital":"10922万元","survey":" 杭州百诚医药科技股份有限公司的主营业务是为各类制药企业、医药研发投资企业提供医药技术受托研发服务（CRO业务）、研发技术成果转化服务、定制研发生产服务（CDMO）。公司的主要产品是药学研究、临床试验、注册申报、研发技术成果转化、定制研发生产服务（CDMO）、自主创新药物研发、受托创新药物研发。","listedPrice":79.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百诚医药(301096)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百诚医药(301096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百诚医药,301096,百诚医药股票,百诚医药股票老虎,百诚医药股票老虎国际,百诚医药行情,百诚医药股票行情,百诚医药股价,百诚医药股市,百诚医药股票价格,百诚医药股票交易,百诚医药股票购买,百诚医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百诚医药(301096)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百诚医药(301096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}